Available Topics
Explore curated workflow pages with resources, guidance, and related reagent products.
Application SolutionsAntibody Solutions for Organ Fibrosis Research
Fibrosis represents a progressive pathological remodeling process characterized by persistent tissue injury, chronic inflammation, fibroblast activation, extracellular matrix (ECM) accumulation, and loss of organ function.
Application SolutionsAntibody Solutions for Immune–Stromal Interaction in Fibrosis Research
Fibrosis represents a dynamic and multifaceted tissue remodeling process driven by continuous interactions among immune cells, stromal populations, extracellular matrix (ECM), and mechanosensitive signaling networks.
Application SolutionsAntibody Solutions for Endothelial-to-Mesenchymal Transition (EndMT) Research
Endothelial-to-mesenchymal transition (EndMT) is a dynamic cellular reprogramming process in which endothelial cells progressively lose vascular characteristics and acquire mesenchymal phenotypes.
Application SolutionsAntibody Solutions for ECM Deposition & Crosslinking Remodeling Research
The extracellular matrix (ECM) is a highly dynamic and biologically active network that provides structural organization, regulates cell–matrix communication, and coordinates tissue homeostasis, regeneration, and disease progression.
Application SolutionsSolutions for Urothelial (Bladder) Cancer Biomarker Research
Urothelial carcinoma (UC), the predominant form of bladder cancer, represents one of the most common malignancies of the urinary tract and is characterized by remarkable molecular heterogeneity, diverse histological phenotypes, frequent recurrence, and variable responses to therapy.
Application SolutionsTumor Biomarker Antibody Solutions for Precision Cancer Research
Cancer diagnosis and treatment have entered an era of molecularly guided precision oncology, where accurate biomarker detection is essential for tumor classification, prognostic evaluation, therapeutic decision-making, and mechanistic investigation.
Application SolutionsSolutions for Tumor Microenvironment & Cancer Immunity Research
The tumor microenvironment (TME) has emerged as a central regulator of cancer progression, immune evasion, therapeutic resistance, and treatment response.
Application SolutionsSolutions for Thyroid Cancer Biomarker Research
Thyroid cancer represents the most common endocrine malignancy, encompassing a broad spectrum of histological subtypes with distinct molecular characteristics, biological behaviors, and therapeutic responses.
Application SolutionsSolutions for Renal Cell Carcinoma Biomarker Research
Renal cell carcinoma (RCC) represents the most common malignant tumor of the kidney and a highly heterogeneous group of cancers with distinct molecular alterations, histological subtypes, and therapeutic responses.
Online Message